Memory CD8+ T cells upregulate glycolysis and effector functions under limiting oxygen conditions

Memory CD8+ T cells are indispensable for maintaining long‐term immunity against intracellular pathogens and tumors. Despite their presence at oxygen‐deprived infected tissue sites or in tumors, the impact of local oxygen pressure on memory CD8+ T cells remains largely unclear. We sought to elucidate how oxygen pressure impacts memory CD8+ T cells arising after infection with Listeria monocytogenes‐OVA. Our data revealed that reduced oxygen pressure during in vitro culture switched CD8+ T cell metabolism from oxidative phosphorylation to a glycolytic phenotype. Quantitative proteomic analysis showed that limiting oxygen conditions increased the expression of glucose transporters and components of the glycolytic pathway, while decreasing TCA cycle and mitochondrial respiratory chain proteins. The altered CD8+ T cell metabolism did not affect the expansion potential, but enhanced the granzyme B and IFN‐γ production capacity. In vivo, memory CD8+ T cells cultured under low oxygen pressure provided protection against bacterial rechallenge. Taken together, our study indicates that strategies of cellular immune therapy may benefit from reducing oxygen during culture to develop memory CD8+ T cells with superior effector functions.

[1]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[2]  D. Cantrell,et al.  Quantitative Analyses Reveal How Hypoxia Reconfigures the Proteome of Primary Cytotoxic T Lymphocytes , 2021, Frontiers in Immunology.

[3]  C. Yee,et al.  Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program , 2021, JCI insight.

[4]  A. Goldrath,et al.  Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells. , 2021, The Journal of clinical investigation.

[5]  M. Kornberg The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity , 2020, Wiley interdisciplinary reviews. Systems biology and medicine.

[6]  J. Paul Robinson,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) , 2019, European journal of immunology.

[7]  David O’Sullivan The metabolic spectrum of memory T cells , 2019, Immunology and cell biology.

[8]  B. Nicolet,et al.  Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses , 2018, The Journal of Immunology.

[9]  V. Badovinac,et al.  Defining Memory CD8 T Cell , 2018, Front. Immunol..

[10]  B. Nelson,et al.  Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study , 2018, Oncoimmunology.

[11]  R. Stark,et al.  Armed and Ready: Transcriptional Regulation of Tissue-Resident Memory CD8 T Cells , 2018, Front. Immunol..

[12]  W. Morrison,et al.  Granzyme B Is an Essential Mediator in CD8+ T Cell Killing of Theileria parva-Infected Cells , 2018, Infection and Immunity.

[13]  T. Kuijpers,et al.  Efficient production of erythroid, megakaryoid and myeloid cells, using single cell-derived iPSC colony differentiation , 2018, bioRxiv.

[14]  E. Pearce,et al.  Unraveling the Complex Interplay Between T Cell Metabolism and Function. , 2018, Annual review of immunology.

[15]  S. Jameson,et al.  Understanding Subset Diversity in T Cell Memory. , 2018, Immunity.

[16]  H. Young,et al.  Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions , 2018, Cell reports.

[17]  I. Amelio,et al.  The hypoxic tumour microenvironment , 2018, Oncogenesis.

[18]  L. Galluzzi,et al.  The spectrum of T cell metabolism in health and disease , 2017, Nature Reviews Immunology.

[19]  Ziv Porat,et al.  Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function. , 2017, Cell reports.

[20]  F. Sánchez‐Madrid,et al.  CD69: from activation marker to metabolic gatekeeper , 2017, European journal of immunology.

[21]  Michael D. Buck,et al.  Metabolic Instruction of Immunity , 2017, Cell.

[22]  F. Sánchez‐Madrid,et al.  CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes , 2017, Oncoimmunology.

[23]  U. V. von Andrian,et al.  The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. , 2016, Immunity.

[24]  J. Neilson,et al.  Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. , 2016, The Journal of clinical investigation.

[25]  O. Kretz,et al.  Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming , 2016, Cell.

[26]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[27]  G. V. D. van der Windt,et al.  Measuring Bioenergetics in T Cells Using a Seahorse Extracellular Flux Analyzer , 2016, Current protocols in immunology.

[28]  Chih-Hao Chang,et al.  Emerging concepts of T cell metabolism as a target of immunotherapy , 2016, Nature Immunology.

[29]  P. Walker,et al.  Phenotypic switch of CD8+ T cells reactivated under hypoxia toward IL‐10 secreting, poorly proliferative effector cells , 2015, European journal of immunology.

[30]  S. Rosenberg,et al.  Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  B. Igyártó,et al.  Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance , 2015, Cell.

[32]  Quynh-Mai Pham,et al.  Oral infection drives a distinct population of intestinal resident memory CD8(+) T cells with enhanced protective function. , 2014, Immunity.

[33]  Ajit S. Divakaruni,et al.  Analysis and interpretation of microplate-based oxygen consumption and pH data. , 2014, Methods in enzymology.

[34]  E. Yang,et al.  Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen , 2013, Nature Immunology.

[35]  C. Hess,et al.  Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch , 2013, Nature Immunology.

[36]  B. Faubert,et al.  CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability , 2013, Proceedings of the National Academy of Sciences.

[37]  B. Faubert,et al.  Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis , 2013, Cell.

[38]  Thomas Gebhardt,et al.  Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.

[39]  J. Licht,et al.  Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. , 2013, Immunity.

[40]  Jeffrey E. Lee,et al.  Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients , 2012, Clinical Cancer Research.

[41]  V. Sondak,et al.  Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma , 2012, Journal of immunotherapy.

[42]  G. V. D. Windt,et al.  Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.

[43]  G. V. D. van der Windt,et al.  Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.

[44]  David K. Finlay,et al.  University of Dundee PDK 1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD 8 T cells , 2012 .

[45]  Matko Bosnjak,et al.  REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.

[46]  S. Steinberg,et al.  Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2011, Clinical Cancer Research.

[47]  W. Burns,et al.  Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. , 2011, Blood.

[48]  J. Rathmell,et al.  The metabolic life and times of a T‐cell , 2010, Immunological reviews.

[49]  Hao Shen,et al.  Quick to remember, slow to forget: rapid recall responses of memory CD8+ T cells , 2010, Cell Research.

[50]  Thomas Gebhardt,et al.  Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus , 2009, Nature Immunology.

[51]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[52]  M. Roederer,et al.  T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.

[53]  E. Wherry,et al.  Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. , 2007, Immunity.

[54]  S. Rosenberg,et al.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.

[55]  L. Herzenberg,et al.  Culturing at atmospheric oxygen levels impacts lymphocyte function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Harty,et al.  CD8+ T cell contraction is controlled by early inflammation , 2004, Nature Immunology.

[57]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[58]  Susan M. Kaech,et al.  Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .

[59]  M. Sitkovsky,et al.  Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions , 2001, The Journal of Immunology.

[60]  Dirk Homann,et al.  Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory , 2001, Nature Medicine.

[61]  Stephen P. Schoenberger,et al.  Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.

[62]  L. Lefrançois,et al.  Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.

[63]  Henrique Veiga-Fernandes,et al.  Response of naïve and memory CD8+ T cells to antigen stimulation in vivo , 2000, Nature Immunology.

[64]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[65]  H. Eisen,et al.  Functional differences between memory and naive CD8 T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. Bevan,et al.  Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.